Please login to the form below

Not currently logged in
Email:
Password:

Global standard for medical writing outlined

International writers' associations aim to strengthen and share best practice
AMWA EMWA ISMPP

Three international medical writing associations have created a new global standard as part of a best practice drive.

It was published by the American Medical Writers Association (AMWA), European Medical Writers Association (EMWA), and the International Society for Medical Publication Professionals (ISMPP).

In a joint statement, they outlined the role of medical writing for scientific journals and presentations and presented a series of guidelines they hope will serve as a “valuable reference for ethical publication practices, worldwide”.

The unified position aims to highlight the value professional medical writing brings to evidence-based medicine in facilitating ethical, accurate and timely disclosure of research results.

EMWA member Dr Chris Winchester said: “By emphasising that professional medical writers are appropriately qualified and follow rigorous guidelines, the joint position statement seeks to strengthen the standing of the profession among journal editors, peer reviewers and readers.”

The statement builds on recommendations from the International Committee of Medical Journal Editors and Good Publication Practice guidelines, describing best practice and providing a template for disclosing medical writing support - particularly with regards to authorship of clinical trial reports.

Between them the AMWA, EMWA and ISMPP have over 6,500 members worldwide, and the joint statement is set to take precedence over each associations' previous positions and guidelines.

Article by
Rebecca Clifford

13th February 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics